These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1969048)

  • 1. Pseudotumor cerebri associated with leuprorelin acetate.
    Arber N; Shirin H; Fadila R; Melamed E; Pinkhas J; Sidi Y
    Lancet; 1990 Mar; 335(8690):668. PubMed ID: 1969048
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary clinical evaluation of leuprorelin acetate depot injection in France, in the management of prostatic cancer.
    Navratil H
    J Int Med Res; 1990; 18 Suppl 1():69-73. PubMed ID: 2108887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with leuprorelin acetate before radiotherapy for prostatic cancer.
    Bourdin S; Karam G; Clemain P; Bouchot O; Peuvrel P; Lacoste J; Auvigne J
    J Int Med Res; 1990; 18 Suppl 1():74-8. PubMed ID: 2108888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudotumour cerebri as a side effect of leuprorelin acetate.
    Boot JH
    Ir J Med Sci; 1996; 165(1):60. PubMed ID: 8867506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudotumour Cerebri Presentation in a Child Under the Gonadotropin-Releasing Hormone Agonist Treatment.
    Gül Ü; Kaçar Bayram A; Kendirci M; Hatipoğlu N; Okdemir D; Gümüş H; Kurtoğlu S
    J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):365-7. PubMed ID: 27087351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of severe fibrocystic disease of the breast with leuprolide acetate.
    Richardson MR; Njemanze J
    Fertil Steril; 1990 Nov; 54(5):942-3. PubMed ID: 2121557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3.75 and 7.5 mg leuprorelin acetate depot in the treatment of advanced prostatic cancer: preliminary report. German Leuprorelin Study Group.
    Bischoff W
    J Int Med Res; 1990; 18 Suppl 1():103-13. PubMed ID: 2108882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leuprorelin acetate depot: results of a multicentre Japanese trial. TAP-144-SR Study Group.
    Akaza H; Aso Y; Koiso K; Fuse H; Isurugi K; Okada K; Usami M; Kotake T; Ohashi T; Ueda T
    J Int Med Res; 1990; 18 Suppl 1():90-102. PubMed ID: 2108889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance liquid chromatography followed by radioimmunoassay for the determination of a luteinizing hormone-releasing hormone analogue, leuprorelin, and its metabolite.
    Ueno H; Matsuo S
    J Chromatogr; 1991 May; 566(1):57-66. PubMed ID: 1909342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudotumor cerebri caused by all-trans-retinoic acid: a case report.
    Tiamkao S; Sirijirachai C
    J Med Assoc Thai; 2000 Nov; 83(11):1420-3. PubMed ID: 11215876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leuprorelin acetate depot in advanced prostatic cancer: a phase II multicentre trial.
    Rizzo M; Mazzei T; Mini E; Bartoletti R; Periti P
    J Int Med Res; 1990; 18 Suppl 1():114-25. PubMed ID: 2108883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical manipulation of leuprorelin acetate to improve clinical performance.
    Toguchi H
    J Int Med Res; 1990; 18 Suppl 1():35-41. PubMed ID: 2138986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudotumor cerebri induced by all-trans retinoic acid treatment of acute promyelocytic leukemia.
    Colucciello M
    Arch Ophthalmol; 2003 Jul; 121(7):1064-5. PubMed ID: 12860824
    [No Abstract]   [Full Text] [Related]  

  • 14. Pseudotumor cerebri caused by all-trans-retinoic acid treatment for acute promyelocytic leukemia.
    Yeh YC; Tang HF; Fang IM
    Jpn J Ophthalmol; 2006; 50(3):295-6. PubMed ID: 16767393
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pseudotumor cerebri with all-trans retinoic acid. A case report].
    Jeddi R; Kacem K; Ben Lakhal R; Aissaoui L; Ben Abid H; Belhadj Ali Z; Meddeb B
    Tunis Med; 2006 Dec; 84(12):827-9. PubMed ID: 17288291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of metastatic carcinoma of the prostate with leuprolide, an LHRH analogue.
    Smith JA
    Prog Clin Biol Res; 1985; 185A():279-85. PubMed ID: 3929267
    [No Abstract]   [Full Text] [Related]  

  • 17. Pseudotumor cerebri as a reversible side effect of all-trans retinoic acid treatment in acute promyelocytic leukaemia.
    Machner B; Neppert B; Paulsen M; Hofmann C; Sander T; Helmchen C
    Eur J Neurol; 2008 Jul; 15(7):e68-9. PubMed ID: 18452541
    [No Abstract]   [Full Text] [Related]  

  • 18. Pseudotumor cerebri due to the potentiation of all-trans retinoic acid by voriconazole.
    Dixon KS; Hassoun A
    J Am Pharm Assoc (2003); 2010; 50(6):742-4. PubMed ID: 21071321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical castration produced by the GnRH analogue leuprolide to treat metastatic breast cancer.
    Harvey HA; Lipton A; Max DT; Pearlman HG; Diaz-Perches R; de la Garza J
    J Clin Oncol; 1985 Aug; 3(8):1068-72. PubMed ID: 3926958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal versus subcutaneous leuprolide: a comparison of acute pharmacodynamic effect.
    Meyer BR; Kreis W; Eschbach J; O'Mara V; Rosen S; Sibalis D
    Clin Pharmacol Ther; 1990 Oct; 48(4):340-5. PubMed ID: 2121407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.